{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T01:34:47Z","timestamp":1792373687955,"version":"4.4.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,12,2]]},"DOI":"10.7759\/cureus.74945","type":"journal-article","created":{"date-parts":[[2024,12,2]],"date-time":"2024-12-02T08:22:01Z","timestamp":1733127721000},"source":"Crossref","is-referenced-by-count":2,"title":["Dupuytren's Contracture: A Review of the Literature"],"prefix":"10.7759","author":[{"given":"Farihah","family":"Khaliq","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chijioke","family":"Orji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1097\/01.prs.0000278455.63546.03","article-title":"Dupuytren's disease: history, diagnosis, and treatment","volume":"120","author":"Shaw RB Jr","year":"2007","unstructured":"Shaw RB Jr, Chong AK, Zhang A, Hentz VR, Chang J. Dupuytren's disease: history, diagnosis, and treatment. Plast Reconstr Surg. 2007, 120:44e-54e. 10.1097\/01.prs.0000278455.63546.03","journal-title":"Plast Reconstr Surg"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.5435\/00124635-199801000-00003","article-title":"Dupuytren's contracture","volume":"6","author":"Benson LS","year":"1998","unstructured":"Benson LS, Williams CS, Kahle M. Dupuytren's contracture. J Am Acad Orthop Surg. 1998, 6:24-35. 10.5435\/00124635-199801000-00003","journal-title":"J Am Acad Orthop Surg"},{"key":"ref3","doi-asserted-by":"crossref","DOI":"10.1016\/S0749-0712(21)00440-6","article-title":"Genetics of Dupuytren's disease","volume":"15","author":"Burge P","year":"1999","unstructured":"Burge P. Genetics of Dupuytren's disease. Hand Clin. 1999, 15:63-71.","journal-title":"Hand Clin"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1308\/003588406X83104","article-title":"Management of Dupuytren's disease--clear advice for an elusive condition","volume":"88","author":"Bayat A","year":"2006","unstructured":"Bayat A, McGrouther DA. Management of Dupuytren's disease--clear advice for an elusive condition. Ann R Coll Surg Engl. 2006, 88:3-8. 10.1308\/003588406X83104","journal-title":"Ann R Coll Surg Engl"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.2106\/00004623-200701000-00026","article-title":"Dupuytren disease: anatomy, pathology, presentation, and treatment","volume":"89","author":"Rayan GM","year":"2007","unstructured":"Rayan GM. Dupuytren disease: anatomy, pathology, presentation, and treatment. J Bone Joint Surg Am. 2007, 89:189-98. 10.2106\/00004623-200701000-00026","journal-title":"J Bone Joint Surg Am"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1038\/s41431-019-0483-5","article-title":"Ethnic differences in prevalence of Dupuytren disease can partly be explained by known genetic risk variants","volume":"27","author":"Riesmeijer SA","year":"2019","unstructured":"Riesmeijer SA, Werker PM, Nolte IM. Ethnic differences in prevalence of Dupuytren disease can partly be explained by known genetic risk variants. Eur J Hum Genet. 2019, 27:1876-84. 10.1038\/s41431-019-0483-5","journal-title":"Eur J Hum Genet"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1302\/0301-620x.79b2.6670","article-title":"Dupuytren's disease may extend beyond the wrist crease in continuity","volume":"79","author":"Sinha A","year":"1997","unstructured":"Sinha A. Dupuytren's disease may extend beyond the wrist crease in continuity. J Bone Joint Surg Br. 1997, 79:211-2. 10.1302\/0301-620x.79b2.6670","journal-title":"J Bone Joint Surg Br"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s40610-016-0045-3","article-title":"Connective tissue degeneration: mechanisms of palmar fascia degeneration (Dupuytren's disease)","volume":"2","author":"Karkampouna S","year":"2016","unstructured":"Karkampouna S, Kreulen M, Obdeijn MC, et al.. Connective tissue degeneration: mechanisms of palmar fascia degeneration (Dupuytren's disease). Curr Mol Biol Rep. 2016, 2:133-40. 10.1007\/s40610-016-0045-3","journal-title":"Curr Mol Biol Rep"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1177\/1753193409349855","article-title":"Spiralling of the neurovascular bundle in Dupuytren's disease","volume":"35","author":"Hettiaratchy S","year":"2010","unstructured":"Hettiaratchy S, Tonkin MA, Edmunds IA. Spiralling of the neurovascular bundle in Dupuytren's disease. J Hand Surg Eur Vol. 2010, 35:103-8. 10.1177\/1753193409349855","journal-title":"J Hand Surg Eur Vol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.cjprs.2024.08.002","article-title":"Dupuytren\u2019s disease: a review","volume":"6","author":"Sarkar M","year":"2024","unstructured":"Sarkar M, Kashyap N, Madabhavi I. Dupuytren\u2019s disease: a review. Chin J Plast Reconstr Surg. 2024, 6:142-8. 10.1016\/j.cjprs.2024.08.002","journal-title":"Chin J Plast Reconstr Surg"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1097\/00007611-199108000-00011","article-title":"Dupuytren's contracture","volume":"84","author":"Riolo J","year":"1991","unstructured":"Riolo J, Young VL, Ueda K, Pidgeon L. Dupuytren's contracture. South Med J. 1991, 84:983-6. 10.1097\/00007611-199108000-00011","journal-title":"South Med J"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1186\/1755-1536-4-14","article-title":"Elevated transforming growth factor \u03b2 and mitogen-activated protein kinase pathways mediate fibrotic traits of Dupuytren's disease fibroblasts","volume":"4","author":"Krause C","year":"2011","unstructured":"Krause C, Kloen P, Ten Dijke P. Elevated transforming growth factor \u03b2 and mitogen-activated protein kinase pathways mediate fibrotic traits of Dupuytren's disease fibroblasts. Fibrogenesis Tissue Repair. 2011, 4:14. 10.1186\/1755-1536-4-14","journal-title":"Fibrogenesis Tissue Repair"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jid.5700613","article-title":"Formation and function of the myofibroblast during tissue repair","volume":"127","author":"Hinz B","year":"2007","unstructured":"Hinz B. Formation and function of the myofibroblast during tissue repair. J Invest Dermatol. 2007, 127:526-37. 10.1038\/sj.jid.5700613","journal-title":"J Invest Dermatol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1038\/nrm809","article-title":"Myofibroblasts and mechano-regulation of connective tissue remodelling","volume":"3","author":"Tomasek JJ","year":"2002","unstructured":"Tomasek JJ, Gabbiani G, Hinz B, Chaponnier C, Brown RA. Myofibroblasts and mechano-regulation of connective tissue remodelling. Nat Rev Mol Cell Biol. 2002, 3:349-63. 10.1038\/nrm809","journal-title":"Nat Rev Mol Cell Biol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1007\/s11552-007-9076-9","article-title":"Gender ratio of Dupuytren's disease in the modern U.S. population","volume":"3","author":"Anthony SG","year":"2008","unstructured":"Anthony SG, Lozano-Calderon SA, Simmons BP, Jupiter JB. Gender ratio of Dupuytren's disease in the modern U.S. population. Hand (N Y). 2008, 3:87-90. 10.1007\/s11552-007-9076-9","journal-title":"Hand (N Y)"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/s0072-968x(77)80023-5","article-title":"Dupuytren's disease\u2014initial symptoms, age of onset and spontaneous course","volume":"9","author":"Mikkelsen OA","year":"1977","unstructured":"Mikkelsen OA. Dupuytren's disease\u2014initial symptoms, age of onset and spontaneous course. Hand. 1977, 9:11-5. 10.1016\/s0072-968x(77)80023-5","journal-title":"Hand"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhsb.2004.06.006","article-title":"Dupuytren's disease risk factors","volume":"29","author":"Geoghegan JM","year":"2004","unstructured":"Geoghegan JM, Forbes J, Clark DI, Smith C, Hubbard R. Dupuytren's disease risk factors. J Hand Surg Br. 2004, 29:423-6. 10.1016\/j.jhsb.2004.06.006","journal-title":"J Hand Surg Br"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.reuma.2012.10.004","article-title":"Clinical anatomy of the hand","volume":"8 Suppl 2","author":"Vargas A","year":"2012","unstructured":"Vargas A, Chiapas-Gasca K, Hern\u00e1ndez-D\u00edaz C, et al.. Clinical anatomy of the hand. Reumatol Clin. 2012, 8 Suppl 2:25-32. 10.1016\/j.reuma.2012.10.004","journal-title":"Reumatol Clin"},{"key":"ref19","article-title":"Dupuytren Contracture","author":"Walthall J","year":"2024","unstructured":"Walthall J, Anand P, Rehman UH. Dupuytren Contracture. StatPearls Publishing, Treasure Island, FL; 2024."},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1007\/s11552-007-9071-1","article-title":"Revised Tubiana's staging system for assessment of disease severity in Dupuytren's disease-preliminary clinical findings","volume":"3","author":"Hindocha S","year":"2008","unstructured":"Hindocha S, Stanley JK, Watson JS, Bayat A. Revised Tubiana's staging system for assessment of disease severity in Dupuytren's disease-preliminary clinical findings. Hand (N Y). 2008, 3:80-6. 10.1007\/s11552-007-9071-1","journal-title":"Hand (N Y)"},{"key":"ref21","article-title":"Prognosis and treatment of Dupuytren's contracture","volume":"37-A","author":"Tubiana R","year":"1955","unstructured":"Tubiana R. Prognosis and treatment of Dupuytren's contracture. J Bone Joint Surg Am. 1955, 37-A:1155-68.","journal-title":"J Bone Joint Surg Am"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhsa.2006.10.003","article-title":"Responsiveness of the Michigan Hand Outcomes Questionnaire and physical measurements in outcome studies of distal radius fracture treatment","volume":"32","author":"Kotsis SV","year":"2007","unstructured":"Kotsis SV, Lau FH, Chung KC. Responsiveness of the Michigan Hand Outcomes Questionnaire and physical measurements in outcome studies of distal radius fracture treatment. J Hand Surg Am. 2007, 32:84-90. 10.1016\/j.jhsa.2006.10.003","journal-title":"J Hand Surg Am"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.12968\/hmed.2012.73.8.432","article-title":"Clostridium histolyticum collagenase in the treatment of Dupuytren's contracture","volume":"73","author":"Azzopardi E","year":"2012","unstructured":"Azzopardi E, Boyce DE. Clostridium histolyticum collagenase in the treatment of Dupuytren's contracture. Br J Hosp Med (Lond). 2012, 73:432-6. 10.12968\/hmed.2012.73.8.432","journal-title":"Br J Hosp Med (Lond)"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1093\/milmed\/usad075","article-title":"Dupuytren's contracture recurrence and treatment following collagenase Clostridium histolyticum injection: a longitudinal assessment in a veteran population","volume":"188","author":"Zarb RM","year":"2023","unstructured":"Zarb RM, Graf AR, Talhelm JE, Stehr RC, Sanger JR, Matloub HS, Daley RA. Dupuytren's contracture recurrence and treatment following collagenase Clostridium histolyticum injection: a longitudinal assessment in a veteran population. Mil Med. 2023, 188:e2975-81. 10.1093\/milmed\/usad075","journal-title":"Mil Med"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhsa.2015.04.036","article-title":"Dupuytren contracture recurrence following treatment with collagenase Clostridium histolyticum (CORDLESS [collagenase option for reduction of Dupuytren long-term evaluation of safety study]): 5-year data","volume":"40","author":"Peimer CA","year":"2015","unstructured":"Peimer CA, Blazar P, Coleman S, Kaplan FT, Smith T, Lindau T. Dupuytren contracture recurrence following treatment with collagenase Clostridium histolyticum (CORDLESS [collagenase option for reduction of Dupuytren long-term evaluation of safety study]): 5-year data. J Hand Surg Am. 2015, 40:1597-605. 10.1016\/j.jhsa.2015.04.036","journal-title":"J Hand Surg Am"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.2106\/JBJS.ST.18.00047","article-title":"Percutaneous needle fasciotomy for Dupuytren contracture","volume":"9","author":"Str\u00f6mberg J","year":"2019","unstructured":"Str\u00f6mberg J. Percutaneous needle fasciotomy for Dupuytren contracture. JBJS Essent Surg Tech. 2019, 9:e6. 10.2106\/JBJS.ST.18.00047","journal-title":"JBJS Essent Surg Tech"},{"key":"ref27","article-title":"Corticosteroid injection in the management of Dupuytren nodules: a review of the literature","volume":"15","author":"Sood A","year":"2015","unstructured":"Sood A, Therattil PJ, Kim HJ, Lee ES. Corticosteroid injection in the management of Dupuytren nodules: a review of the literature. Eplasty. 2015, 15:e42.","journal-title":"Eplasty"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.13773","article-title":"To remember: radiotherapy - a successful treatment for early Dupuytren's disease","volume":"30","author":"Eberlein B","year":"2016","unstructured":"Eberlein B, Biedermann T. To remember: radiotherapy - a successful treatment for early Dupuytren's disease. J Eur Acad Dermatol Venereol. 2016, 30:1694-9. 10.1111\/jdv.13773","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcot.2020.03.026","article-title":"Dupuytren's contracture - current concepts","volume":"11","author":"Dutta A","year":"2020","unstructured":"Dutta A, Jayasinghe G, Deore S, Wahed K, Bhan K, Bakti N, Singh B. Dupuytren's contracture - current concepts. J Clin Orthop Trauma. 2020, 11:590-6. 10.1016\/j.jcot.2020.03.026","journal-title":"J Clin Orthop Trauma"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1053\/jhsu.2000.6918","article-title":"Enzyme injection as nonsurgical treatment of Dupuytren's disease","volume":"25","author":"Badalamente MA","year":"2000","unstructured":"Badalamente MA, Hurst LC. Enzyme injection as nonsurgical treatment of Dupuytren's disease. J Hand Surg Am. 2000, 25:629-36. 10.1053\/jhsu.2000.6918","journal-title":"J Hand Surg Am"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1007\/s00402-024-05320-7","article-title":"Long-term recurrence of Dupuytren's disease treated with Clostridium histolitycum collagenase. Surgical treatment and anatomopathological study","volume":"144","author":"Sim\u00f3n-P\u00e9rez C","year":"2024","unstructured":"Sim\u00f3n-P\u00e9rez C, Rodr\u00edguez-Mateos JI, Maestro IA, Alvarez-Qui\u00f1ones M, Simon-Perez E, Mart\u00edn-Ferrero MA. Long-term recurrence of Dupuytren's disease treated with Clostridium histolitycum collagenase. Surgical treatment and anatomopathological study. Arch Orthop Trauma Surg. 2024, 144:2085-91. 10.1007\/s00402-024-05320-7","journal-title":"Arch Orthop Trauma Surg"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1177\/1558944721994220","article-title":"Outcomes of management of recurrent Dupuytren contracture: a systematic review and meta-analysis","volume":"17","author":"Wong CR","year":"2022","unstructured":"Wong CR, Huynh MN, Fageeh R, McRae MC. Outcomes of management of recurrent Dupuytren contracture: a systematic review and meta-analysis. Hand (N Y). 2022, 17:1104-13. 10.1177\/1558944721994220","journal-title":"Hand (N Y)"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhsa.2021.04.014","article-title":"Pediatric hand fractures and congenital differences: an analysis of data from the American Board of Orthopaedic Surgery and the American Board of Plastic Surgery","volume":"47","author":"Goldfarb CA","year":"2022","unstructured":"Goldfarb CA, Wall LB, Brandt K, Nielsen E, Flynn JM, Hosseinzadeh P. Pediatric hand fractures and congenital differences: an analysis of data from the American Board of Orthopaedic Surgery and the American Board of Plastic Surgery. J Hand Surg Am. 2022, 47:191.e1-7. 10.1016\/j.jhsa.2021.04.014","journal-title":"J Hand Surg Am"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1177\/1753193414560511","article-title":"A review of the classification of Dupuytren's disease","volume":"40","author":"Akhavani MA","year":"2015","unstructured":"Akhavani MA, McMurtrie A, Webb M, Muir L. A review of the classification of Dupuytren's disease. J Hand Surg Eur Vol. 2015, 40:155-65. 10.1177\/1753193414560511","journal-title":"J Hand Surg Eur Vol"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2474-14-131","article-title":"Optimal functional outcome measures for assessing treatment for Dupuytren\u2019s disease: a systematic review and recommendations for future practice","volume":"14","author":"Ball C","year":"2013","unstructured":"Ball C, Pratt AL, Nanchahal J. Optimal functional outcome measures for assessing treatment for Dupuytren\u2019s disease: a systematic review and recommendations for future practice. BMC Musculoskelet Disord. 2013, 14:131. 10.1186\/1471-2474-14-131","journal-title":"BMC Musculoskelet Disord"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1177\/1753193415601350","article-title":"Validity of the disabilities of the arm, shoulder and hand patient-reported outcome measure (DASH) and the QuickDASH when used in Dupuytren's disease","volume":"41","author":"Rodrigues J","year":"2016","unstructured":"Rodrigues J, Zhang W, Scammell B, et al.. Validity of the disabilities of the arm, shoulder and hand patient-reported outcome measure (DASH) and the QuickDASH when used in Dupuytren's disease. J Hand Surg Eur Vol. 2016, 41:589-99. 10.1177\/1753193415601350","journal-title":"J Hand Surg Eur Vol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/314323-dupuytrens-contracture-a-review-of-the-literature","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,2]],"date-time":"2024-12-02T08:22:03Z","timestamp":1733127723000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/314323-dupuytrens-contracture-a-review-of-the-literature"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,2]]},"references-count":36,"URL":"https:\/\/doi.org\/10.7759\/cureus.74945","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12,2]]}}}